Opes Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Buy |
171,017
+13,690
| +9% | +$1.52M | 3.37% | 5 |
|
|
2025
Q1 | $17.6M | Buy |
157,327
+118
| +0.1% | +$13.2K | 3.56% | 4 |
|
|
2024
Q4 | $14.5M | Buy |
157,209
+120
| +0.1% | +$11.1K | 2.98% | 5 |
|
|
2024
Q3 | $13.2M | Sell |
157,089
-1,662
| -1% | -$139K | 2.53% | 5 |
|
|
2024
Q2 | $10.9M | Buy |
158,751
+244
| +0.2% | +$16.7K | 2.27% | 8 |
|
|
2024
Q1 | $11.6M | Buy |
158,507
+531
| +0.3% | +$38.9K | 2.68% | 5 |
|
|
2023
Q4 | $12.8M | Sell |
157,976
-277
| -0.2% | -$22.4K | 3.07% | 5 |
|
|
2023
Q3 | $11.9M | Buy |
158,253
+676
| +0.4% | +$50.7K | 3.29% | 5 |
|
|
2023
Q2 | $12.1M | Buy |
157,577
+261
| +0.2% | +$20.1K | 3.44% | 4 |
|
|
2023
Q1 | $13.1M | Buy |
157,316
+1,078
| +0.7% | +$89.4K | 4.21% | 4 |
|
|
2022
Q4 | $13.4M | Buy |
156,238
+10,290
| +7% | +$883K | 4.87% | 3 |
|
|
2022
Q3 | $9M | Buy |
145,948
+1,338
| +0.9% | +$82.5K | 3.6% | 4 |
|
|
2022
Q2 | $8.94M | Buy |
144,610
+1,791
| +1% | +$111K | 3.58% | 4 |
|
|
2022
Q1 | $8.49M | Hold |
142,819
| – | – | 2.76% | 7 |
|
|
2021
Q4 | $10.4M | Sell |
142,819
-7,500
| -5% | -$545K | 3.22% | 5 |
|
|
2021
Q3 | $10.5M | Buy |
150,319
+1,873
| +1% | +$131K | 3.71% | 4 |
|
|
2021
Q2 | $10.2M | Buy |
148,446
+50,700
| +52% | +$3.49M | 3.78% | 5 |
|
|
2021
Q1 | $6.32M | Hold |
97,746
| – | – | 2.46% | 14 |
|
|
2020
Q4 | $5.7M | Hold |
97,746
| – | – | 2.74% | 13 |
|
|
2020
Q3 | $6.18M | Buy |
97,746
+100
| +0.1% | +$6.32K | 2.95% | 9 |
|
|
2020
Q2 | $7.23M | Buy |
+97,646
| New | +$7.23M | 3.68% | 8 |
|